New cancer clinical trial: Carboplatin +/- Nivolumab in Metastatic Triple Negative Breast Cancer
Published on: January 30, 2018 at 12:00PM
Condition: Breast Cancer
Interventions: Drug: Carboplatin; Drug: Nivolumab
Sponsors: Dana-Farber Cancer Institute; Bristol-Myers Squibb
Not yet recruiting
http://ift.tt/2DN4mY2
More Stories
‘My 401k Misses You’: Black Woman Pumped To Meet Donald Trump In Philadelphia – July 18, 2023 at 04:56PM
Energy Provider Warns of Impending ‘Crisis,’ ‘Blackout Conditions’ Driven By Biden Plans – July 18, 2023 at 04:20PM
Dog starts barking at cows crossing a bridge, so the cows stop to have a look. – July 17, 2023 at 02:27PM